1,469
Participants
Start Date
December 31, 2003
Primary Completion Date
March 31, 2006
Study Completion Date
March 31, 2006
Copegus
400mg po bid for 16 weeks
Copegus
400mg po bid for 24 weeks
peginterferon alfa-2a [Pegasys]
180 micrograms sc weekly for 16 weeks
peginterferon alfa-2a [Pegasys]
180 micrograms sc weekly for 24 weeks
Melbourne
Brisbane
Woolloongabba
Adelaide
New York
New York
The Bronx
Manhasset
Bayside
Marseille
Berlin
Binghamton
Williamsville
Pittsburgh
Hershey
Milan
Baltimore
Baltimore
Falls Church
Charlottesville
Richmond
Kiel
Bergamo
Pavia
Durham
Madrid
Madrid
Madrid
Fayetteville
Statesville
Austell
Atlanta
Hanover
Toulouse
Jacksonville
Jacksonville
Pensacola
Orlando
Miami
Wellington
Tampa
Bradenton
Rennes
Birmingham
Mobile
Germantown
La Tronche
Bologna
Düsseldorf
Seville
Cleveland
Valencia
Indianapolis
Barakaldo
Iowa City
Iowa City
Madison
Vandœuvre-lès-Nancy
Minneapolis
Plymouth
Pisa
Moline
St Louis
Homburg/saar
Strasbourg
New Orleans
Baton Rouge
Little Rock
Dallas
Houston
Freiburg im Breisgau
Littleton
Napoli
Cheyenne
Boise
Salt Lake City
Phoenix
Scottsdale
Albuquerque
Los Angeles
Long Beach
San Diego
Clichy
San Diego
San Diego
San Luis Obispo
Créteil
San Francisco
San Francisco
Honolulu
Portland
Bellevue
Kirkland
Seattle
Seattle
Puyallup
Anchorage
La Jolla
Palo Alto
Sacramento
Farmington
Gainesville
Boston
Boston
Burlington
Worcester
Ann Arbor
Detroit
Chapel Hill
Cincinnati
Lancaster
Cranston
Providence
Dallas
Fort Sam Houston
White River Junction
Chesapeake
Spokane
Kingswood
Otahuhu
Edmonton
Downsview
Mississauga
Nice
Ponce
San Juan
San Juan
Santurce
Badalona
Barcelona
Barcelona
Madrid
Hoffmann-La Roche
INDUSTRY